Sadahiro Naka

1.1k total citations
51 papers, 631 citations indexed

About

Sadahiro Naka is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sadahiro Naka has authored 51 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Radiology, Nuclear Medicine and Imaging, 17 papers in Oncology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sadahiro Naka's work include Radiopharmaceutical Chemistry and Applications (22 papers), Medical Imaging Techniques and Applications (20 papers) and Amino Acid Enzymes and Metabolism (11 papers). Sadahiro Naka is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (22 papers), Medical Imaging Techniques and Applications (20 papers) and Amino Acid Enzymes and Metabolism (11 papers). Sadahiro Naka collaborates with scholars based in Japan, Germany and United Kingdom. Sadahiro Naka's co-authors include Tadashi Watabe, Jun Hatazawa, Eku Shimosegawa, Yasukazu Kanai, Hiroki Kato, Kayako Isohashi, Genki Horitsugi, Frederik L. Giesel, Hayato Ikeda and Yuwei Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Sadahiro Naka

49 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sadahiro Naka Japan 14 402 237 130 86 82 51 631
Kayako Isohashi Japan 15 504 1.3× 94 0.4× 168 1.3× 102 1.2× 45 0.5× 58 773
G. Meyer Germany 15 490 1.2× 283 1.2× 260 2.0× 130 1.5× 81 1.0× 28 989
Yuwei Liu Japan 9 291 0.7× 372 1.6× 110 0.8× 150 1.7× 116 1.4× 20 614
Claudia Bacher-Stier Germany 11 379 0.9× 79 0.3× 99 0.8× 61 0.7× 139 1.7× 16 630
Ganghua Tang China 12 275 0.7× 167 0.7× 55 0.4× 78 0.9× 171 2.1× 54 548
Yoshifumi Shirakami Japan 20 737 1.8× 470 2.0× 355 2.7× 185 2.2× 226 2.8× 55 1.3k
Shelly X. Bian United States 13 105 0.3× 189 0.8× 320 2.5× 73 0.8× 24 0.3× 37 632
James W. Brodack United States 16 629 1.6× 179 0.8× 138 1.1× 56 0.7× 135 1.6× 18 862
Mareike Roscher Germany 14 235 0.6× 129 0.5× 169 1.3× 29 0.3× 43 0.5× 28 596
Naoto Shikano Japan 13 202 0.5× 94 0.4× 95 0.7× 25 0.3× 66 0.8× 45 546

Countries citing papers authored by Sadahiro Naka

Since Specialization
Citations

This map shows the geographic impact of Sadahiro Naka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sadahiro Naka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sadahiro Naka more than expected).

Fields of papers citing papers by Sadahiro Naka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sadahiro Naka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sadahiro Naka. The network helps show where Sadahiro Naka may publish in the future.

Co-authorship network of co-authors of Sadahiro Naka

This figure shows the co-authorship network connecting the top 25 collaborators of Sadahiro Naka. A scholar is included among the top collaborators of Sadahiro Naka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sadahiro Naka. Sadahiro Naka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Watabe, Tadashi, Sadahiro Naka, Yoshifumi Shirakami, et al.. (2025). Development of PSMA-Targeted Alpha Therapy Using [211At]PSMA-5. Seminars in Nuclear Medicine. 55(6). 947–954. 1 indexed citations
3.
Naka, Sadahiro, Kazuhiro Ooe, Yoshifumi Shirakami, et al.. (2024). Production of [211At]NaAt solution under GMP compliance for investigator-initiated clinical trial. EJNMMI Radiopharmacy and Chemistry. 9(1). 29–29. 9 indexed citations
4.
Watabe, Tadashi, Koji Hatano, Sadahiro Naka, et al.. (2024). First-in-human SPECT/CT imaging of [211At]PSMA-5: targeted alpha therapy in a patient with refractory prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 52(7). 2253–2255. 10 indexed citations
5.
Abe, Kaori, Tadashi Watabe, Kazuko Kaneda‐Nakashima, et al.. (2024). Evaluation of Targeted Alpha Therapy Using [211At]FAPI1 in Triple-Negative Breast Cancer Xenograft Models. International Journal of Molecular Sciences. 25(21). 11567–11567. 2 indexed citations
6.
Watabe, Tadashi, Takahito Fukusumi, Hidenori Inohara, et al.. (2023). Activated fibroblasts in muscle sarcoidosis revealed by [18F]FAPI-74 PET. European Journal of Nuclear Medicine and Molecular Imaging. 50(11). 3481–3482. 2 indexed citations
7.
Watabe, Tadashi, Kazuya Kabayama, Sadahiro Naka, et al.. (2023). Immuno-PET and Targeted α-Therapy Using Anti–Glypican-1 Antibody Labeled with89Zr or211At: A Theranostic Approach for Pancreatic Ductal Adenocarcinoma. Journal of Nuclear Medicine. 64(12). 1949–1955. 13 indexed citations
8.
Naka, Sadahiro, Toshimitsu Watanabe, Yasukazu Kanai, et al.. (2022). Improved Stability and Practicality for Synthesis of 4-Borono-2-[18F]fluoro-l-phenylalanine by Combination of [18O]O2 Single-Use and [18F]CH3COOF Labeling Agents. Nuclear Medicine and Molecular Imaging. 56(2). 86–95. 3 indexed citations
9.
Tatsumi, Mitsuaki, Sadahiro Naka, Kazuhiro Ooe, et al.. (2022). Advantages of FBPA PET in evaluating early response of anti-PD-1 immunotherapy in B16F10 melanoma-bearing mice: Comparison to FDG PET. Frontiers in Oncology. 12. 1026608–1026608. 1 indexed citations
10.
Liu, Yuwei, Tadashi Watabe, Kazuko Kaneda‐Nakashima, et al.. (2021). Fibroblast activation protein targeted therapy using [177Lu]FAPI-46 compared with [225Ac]FAPI-46 in a pancreatic cancer model. European Journal of Nuclear Medicine and Molecular Imaging. 49(3). 871–880. 134 indexed citations
11.
Isohashi, Kayako, Genki Horitsugi, Yasukazu Kanai, et al.. (2019). Evaluation of the total distribution volume of 18F-FBPA in normal tissues of healthy volunteers by non-compartmental kinetic modeling. Annals of Nuclear Medicine. 34(3). 155–162. 14 indexed citations
12.
Tani, Naoki, Tadashi Watabe, Tatsuya Sakai, et al.. (2018). Difference of transport efflux in the rat C6 gliomas: comparative PET study between L and D-isomer of 11C-Methionine.. 59. 1278–1278. 1 indexed citations
13.
Nishijima, Ken‐ichi, Yasukazu Kanai, Sadahiro Naka, et al.. (2018). Measurement of Iodine-Derived Contamination in L-[<sup>11</sup>C]Methionine Injection. RADIOISOTOPES. 67(3). 75–83. 1 indexed citations
14.
Watabe, Tadashi, Kohei Hanaoka, Sadahiro Naka, et al.. (2017). Practical calculation method to estimate the absolute boron concentration in tissues using 18F-FBPA PET. Annals of Nuclear Medicine. 31(6). 481–485. 25 indexed citations
15.
Horitsugi, Genki, Tadashi Watabe, Yasukazu Kanai, et al.. (2017). Oxygen-15 labeled CO2, O2, and CO PET in small animals: evaluation using a 3D-mode microPET scanner and impact of reconstruction algorithms. EJNMMI Research. 7(1). 91–91. 13 indexed citations
17.
Imaizumi, Masao, Yasukazu Kanai, Sadahiro Naka, et al.. (2012). Dynamic whole-body imaging of 18kDa translocator protein using C11-PBR28 and 3D-PET/CT in Asian. 53. 1889–1889. 1 indexed citations
18.
Hirata, Masahiko, Yasukazu Kanai, Sadahiro Naka, et al.. (2012). Synthesis and evaluation of radioiodinated phenoxyquinazoline and benzylaminoquinazoline derivatives as new EGF receptor tyrosine kinase imaging ligands for tumor diagnosis using SPECT. Annals of Nuclear Medicine. 26(5). 381–389. 5 indexed citations
19.
Yanagië, Hironobu, Hisao Kobayashi, Y Takeda, et al.. (2002). Inhibition of growth of human breast cancer cells in culture by neutron capture using liposomes containing 10B. Biomedicine & Pharmacotherapy. 56(2). 93–99. 11 indexed citations
20.
Akashi, A, T Hashizume, Masahiro Tanaka, et al.. (1980). Pharmacological studies on ticlopidine, a new platelet aggregation inhibitor. Part II: General pharmacological properties.. PubMed. 30(3). 415–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026